Kilian Mullett

Kilian is a highly accomplished pharmaceutical professional with a rich history spanning back to 1994, when he commenced his journey with esteemed organizations like Schering-Plough, Washington Group, Wyeth Biotech, and his current role at Pfizer. Educationally, he holds a degree in industrial biology, complemented by an MBS in strategy and finance, as well as a postgraduate diploma in executive leadership. Throughout the early phases of his career, he excelled in leadership roles, spearheading teams in the establishment of greenfield pharmaceutical plants, overseeing capital projects, and demonstrating effectiveness in operations management. Over the years, his trajectory led him to become the global portfolio leader for Pfizer’s localization initiatives, where he has played a pivotal role in facilitating the global transfer of vaccine and small molecule technologies to emerging and developed markets. In his most recent position, Kilian has assumed a leadership role in both technical and supply aspects within Pfizer’s vaccines business development, while also steering small and large molecule business development endeavors for emerging markets, with a particular focus on emerging markets and China. Currently, Kilian is instrumental in crafting and executing commercial supply strategies for Pfizer’s equity, pandemic preparedness, and global product localization programs. He is the Pfizer global supply representative on the IFPMA Africa manufacturing committee.